Great question, and yes — increased anxiety on GLP-1 RAs is reported, though the mechanism isn't fully clear. Likely related to altered gut-brain axis signaling and possibly changes in blood sugar dynamics.
Here's a comparison of the two peptides:
Selank (TP-7 / Thr-Lys-Pro-Arg-Pro-Gly-Pro):
- Synthetic analog of the immunomodulatory peptide tuftsin
- Primary mechanism: modulation of GABAergic neurotransmission, with effects on BDNF expression and monoamine metabolism
- Key study: Zozulya et al. (2008, PMID: 18577369) — demonstrated anxiolytic effects comparable to medazepam in GAD patients in a clinical trial
- Also shown to modulate IL-6 and influence enkephalin metabolism (Seredenin et al., 2013)
- Approved in Russia as an anxiolytic (trade name: Selank nasal spray)
Semax (Met-Glu-His-Phe-Pro-Gly-Pro):
- Synthetic analog of ACTH(4-10), the fragment of adrenocorticotropic hormone responsible for nootropic effects
- Primary mechanism: BDNF upregulation, modulation of dopaminergic and serotonergic systems, neurotrophic effects
- Key study: Eremin et al. (2004, PMID: 15341466) — showed improved cognitive function and reduced anxiety in patients with cognitive impairment
- Stronger nootropic profile than Selank; approved in Russia for stroke recovery and cognitive enhancement
TL;DR: Selank is the more anxiolytic-focused peptide. Semax is more of a cognitive enhancer with secondary anxiolytic effects. For your stated goal of managing anxiety, Selank is probably the better starting point.